Profilo
Nathan Chen worked as the Director of Regional Clinical Development at Boehringer Ingelheim Corp.
He then served as the Head of Immunology & Inflammation at GSK Plc from 2018 to 2020.
Currently, he is the Vice President of Regulatory Affairs at LianBio.
Mr. Chen holds graduate degrees from Purdue University, Rensselaer Polytechnic Institute, and the State University of New York at Albany.
Precedenti posizioni note di Nathan Chen
Società | Posizione | Fine |
---|---|---|
LIANBIO | Consigliere Generale | 01/02/2023 |
GSK PLC | Corporate Officer/Principal | 01/02/2020 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Formazione di Nathan Chen
Purdue University | Graduate Degree |
Rensselaer Polytechnic Institute | Graduate Degree |
State University of New York at Albany | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LIANBIO | Health Technology |
GSK PLC | Health Technology |
Aziende private | 1 |
---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Nathan Chen